The efficacy and safety of Fufangdanshen tablets (Radix Salviae miltiorrhizae formula tablets) for mild to moderate vascular dementia: a study protocol for a randomized controlled trial

BACKGROUND: Vascular dementia (VaD) is the second most common subtype of dementia after Alzheimer's disease (AD). Currently, there are no medications approved for treating patients with VaD. Fufangdanshen (FFDS) tablets (Radix Salviae miltiorrhizae formula tablets) are a traditional Chinese med...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Trials
Hlavní autoři: Tian, Jinzhou, Shi, Jing, Wei, Mingqing, Qin, Renan, Ni, Jingnian, Zhang, Xuekai, Li, Ting, Wang, Yongyan
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2016
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4897894/
https://ncbi.nlm.nih.gov/pubmed/27266867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-016-1410-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky